Current U.S. law does not prohibit the importation of medications from Canada, but concern arose from the possibility that the U.S. may move to tighten restrictions on pharmaceuticals from Canada.
The international pharmacy industry employs thousands of Canadians directly and indirectly. Bill C-282 was criticized as a threat to Canadian industry and sovereignty and a sell-out to U.S. drug manufacturers opposed to imports from Canada.
Robert Thibault, the Parliamentary Secretary for the Minister of Health, announced in the House of Commons on December 1, “(I)t is important to highlight that the bill does not have the support of the Minister of Health, the Minister of State for Public Health nor the Minister of International Trade.” Thibault also criticized the bill because it "puts on Canada the burden of enforcing the laws of the U.S. and other countries respecting the importation of prescription drugs.
“MP Peter Julian (Burnaby-New Westminster, NDP) referred to U.S. laws affecting softwood lumber and beef that 'were put into place as basically fences for Canadian exports.'
“(I)t is important to highlight that the bill does not have the support of the Minister of Health, the Minister of State for Public Health nor the Minister of International Trade.” |
The Canadian international pharmacy industry employs an estimated 4000 Canadians directly and a much larger number of Canadians indirectly in supporting industries such as Canadian generic drug makers, pharmaceutical wholesalers, website development companies and computer programming firms.